Metformin (generic), Glucophage News

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Despite prior research suggesting that the widely used diabetes drug metformin might help cancer patients, a new study finds it does not boost survival for older breast cancer patients with diabetes.

In Eastport accident on CR-51/East Moriches Riverhead Rd at Eastport Manor Rd. Slow traffic from Rt-27/Sunrise Hwy in Suffolk In Eastport accident on CR-51/East Moriches Riverhead Rd at Eastport Manor Rd.

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.

Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction.

Epidemiological studies have shown direct associations between type 2 diabetes and obesity, both conditions associated with hyperglycaemia and hyperinsulinemia, and the risk of pancreatic cancer.

The oral diabetes drug metformin may slow the aging process by mimicking the effects of a calorie-restricted diet, according to a new animal study from the United Kingdom.

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.

THE DIABETES drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy, according to a study published in the British Journal of Cancer this week.

The diabetes drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy, according to a study published in the British Journal of Cancer today.

The fixed combination of the drugs saxagliptin and metformin has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus.

Merck and Pfizer have entered into a worldwide collaboration for the development and commercialization of Pfizer's ertugliflozin , an investigational oral sodium glucose cotransporter inhibitor for the treatment of type 2 diabetes.

People with chronic medical conditions who wear a medical identification bracelet are making a simple decision that could save their life in an emergency.

The Food and Drug Administration has given tentative approval to two generic diabetes drugs made by Sun Pharmaceutical Industries, the Indian drug maker said.